The DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.
Cytokine storm intervention in the early stages of COVID-19 pneumonia
Open accessAbstract
Clinical intervention in patients with corona virus disease 2019 (COVID-19) has demonstrated a strong upregulation of cytokine production in patients who are critically ill with SARS-CoV2-induced pneumonia. In a retrospective study of 41 patients with COVID-19, most patients with SARS-CoV-2 infection developed mild symptoms, whereas some patients later developed aggravated disease symptoms, and eventually passed away because of multiple organ dysfunction syndrome (MODS), as a consequence of a severe cytokine storm. Guidelines for the diagnosis and treatment of SARS-CoV-2 infected pneumonia were first published January 30th, 2020; these guidelines recommended for the first time that cytokine monitoring should be applied in severely ill patients to reduce pneumonia related mortality. The cytokine storm observed in COVID-19 illness is also an important component of mortality in other viral diseases, including SARS, MERS and influenza. In view of the severe morbidity and mortality of COVID-19 pneumonia, we review the current understanding of treatment of human coronavirus infections from the perspective of a dysregulated cytokine and immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“pro-inflammatory factors are intensely released, the so-called “cytokine storm”, which enter the bloodstream, and reach other organs (Fig. 1A) [9].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [9]
In the citing paper
“Cytokine storms have been reported in several viral infections [96], including SARS-CoV-2 [9, 97].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [9]
In the citing paper
“Patients infected with SARS-CoV-2 present elevated levels of IL-6, IL-10, IL-1β, INF-γ, CCL2, TNF-α, CXCL10, CCL7, IL-1 receptor antagonist and IL-2 receptor, supposedly associated with disease severity [9, 98–105].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationChen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citationWang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Wu, J. T., Leung, K., & Leung, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30260-9 · Cited by 4,389
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Jin, Y., Cai, L., Cheng, Z., Cheng, H., Deng, T., Fan, Y., Fang, C., Huang, D., Huang, L., Huang, Q., et al. (2020) · Military Medical Research · doi:10.1186/s40779-020-0233-6 · Cited by 2,306
Shimabukuro‐Vornhagen, A., Gödel, P., Subklewe, M. S., Stemmler, H., Schlößer, H., Schlaak, M. S., Kochanek, M., Böll, B., & von Bergwelt‐Baildon, M. S. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0343-9 · Cited by 1,712
Tian, S., Hu, W., Niu, L., Liu, H., Xu, H., & Xiao, S. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.02.010 · Cited by 1,428
Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. M. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,400
Imai, Y., Kuba, K., Neely, G. G., Yaghubian-Malhami, R., Perkmann, T., van Loo, G., Ermolaeva, M., Veldhuizen, R., Leung, Y. H. C., Wang, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.043 · Cited by 1,356
SARS: systematic review of treatment effects
Stockman, L. J., Bellamy, R., & Garner, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030343 · Cited by 1,217
Hay, K. A., Hanafi, L.-A., Li, D., Gust, J., Liles, W. C., Wurfel, M. M., López, J. A., Chen, J., Chung, D., Harju-Baker, S., et al. (2017) · Blood · doi:10.1182/blood-2017-06-793141 · Cited by 1,156
Self-citationTherapeutic siRNA silencing in inflammatory monocytes in mice
Leuschner, F., Dutta, P., Gorbatov, R., Novobrantseva, T. I., Donahoe, J. S., Courties, G., Lee, K. M., Kim, J. I., Markmann, J. F., Marinelli, B., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1989 · Cited by 839
Immunotherapeutic Implications of Il-6 Blockade for Cytokine Storm
Tanaka, T., Narazaki, M., & Kishimoto, T. (2016) · Immunotherapy · doi:10.2217/imt-2016-0020 · Cited by 719
Teijaro, J. R., Walsh, K. B., Cahalan, S., Fremgen, D. M., Roberts, E., Scott, F., Martinborough, E., Peach, R., Oldstone, M. B. A., & Rosen, H. (2011) · Cell · doi:10.1016/j.cell.2011.08.015 · Cited by 688
Preparing for the Next Pandemic
Osterholm, M. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058068 · Cited by 665
Omrani, A. S., Saad, M. M., Baig, K. M., Bahloul, A., Abdul-Matin, M., Aidaroos, A. Y. A., Almakhlafi, G. A., Albarrak, M. M., Memish, Z. A., & Albarrak, A. M. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70920-x · Cited by 491
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons
Nile, S. H., Nile, A. S., Qiu, J., Li, L., Jia, X., & Kai, G. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.002 · Cited by 452
The TLR4 antagonist Eritoran protects mice from lethal influenza infection
Shirey, K. A., Lai, W., Scott, A. J., Lipsky, M., Mistry, P., Pletneva, L. M., Karp, C. L., McAlees, J. W., Gioannini, T. L., Weiss, J. P., et al. (2013) · Nature · doi:10.1038/nature12118 · Cited by 426
Min, C.-K., Cheon, S., Ha, N., Sohn, K. M., Kim, Y., Aigerim, A., Shin, H. M., Choi, J., Inn, K., Kim, J. H., et al. (2016) · Scientific Reports · doi:10.1038/srep25359 · Cited by 364
Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock
Pathan, N., Hemingway, C. A., Alizadeh, A. A., Stephens, A. C., Boldrick, J. C., Oragui, E. E., McCabe, C., Welch, S. B., Whitney, A. R., O’Gara, P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15326-3 · Cited by 358
Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome
Reghunathan, R., Jayapal, M., Hsu, L. Y., Chng, H. H., Tai, D. Y. H., Leung, B. P. L., & Melendez, A. J. (2005) · BMC Immunology · doi:10.1186/1471-2172-6-2 · Cited by 295
Chien, J., Hsueh, P., Cheng, W., Yu, C., & Yang, P. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00942.x · Cited by 225
Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection
Teijaro, J. R., Walsh, K. B., Rice, S., Rosen, H., & Oldstone, M. B. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400593111 · Cited by 224
High–Dose Pulse Versus Nonpulse Corticosteroid Regimens in Severe Acute Respiratory Syndrome
Ho, J., OOI, G. C., Mok, T., Chan, J. W. M., Hung, I. F., LAM, B. K., Wong, P. C., Li, P. C., Ho, P., Lam, W. K., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200306-766oc · Cited by 208
Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020
Bajema, K. L., Oster, A. M., McGovern, O. L., Lindstrom, S., Stenger, M., Anderson, T. C., Isenhour, C. J., Clarke, K. R., Evans, M. E., Chu, V. T., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6906e1 · Cited by 200
Menachery, V. D., Schäfer, A., Burnum-Johnson, K., Mitchell, H. D., Eisfeld, A. J., Walters, K., Nicora, C., Purvine, S. O., Casey, C., Monroe, M. E., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706928115 · Cited by 193
Immunomodulatory therapy for severe influenza
Darwish, I., Mubareka, S., & Liles, W. C. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.56 · Cited by 129
Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong
Yam, L. Y.-C., Lau, A. C.-W., Lai, F. Y.-L., Shung, E., Chan, J., & Wong, V. C. W. (2006) · Journal of Infection · doi:10.1016/j.jinf.2006.01.005 · Cited by 100
Mediator removal with CRRT: Complement and cytokines
Silvester, W. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90541-2 · Cited by 90
TSANG, K. W. T., & Zhong, N. (2003) · Respirology · doi:10.1046/j.1440-1843.2003.00525.x · Cited by 63
Interaction of Angiotensin II and Atrial Natriuretic Peptide in the Human Fetoplacental Unit
McQueen, J., Jardine, A. G., Kingdom, J. C., Templeton, A. G. B., Whittle, M. J., & Connell, J. (1990) · American Journal of Hypertension · doi:10.1093/ajh/3.8.641 · Cited by 33
Research works printed but not linked: 3
- Tian, 2020, Pulmonary pathology of early phase SARS-COV-2 pneumonia, Preprints
- Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, 10.1001/jama.2020.1585 · DOI · Paper page
- Xu, 2020, Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Lancet Respir. Med., 10.1016/S2213-2600(20)30076-X · DOI · Paper page
Cited by
Sorted by citations
The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections
Machhi, J., Herskovitz, J., Senan, A. M., Dutta, D., Nath, B., Oleynikov, M. D., Blomberg, W. R., Meigs, D. D., Hasan, M., Patel, M., et al. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09944-5 · Cited by 642
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons
Nile, S. H., Nile, A. S., Qiu, J., Li, L., Jia, X., & Kai, G. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.002 · Cited by 452
Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome
Villapol, S. (2020) · Translational research · doi:10.1016/j.trsl.2020.08.004 · Cited by 341
Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome
Afrin, L. B., Weinstock, L. B., & Molderings, G. J. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.016 · Cited by 319
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation
Kempuraj, D., Selvakumar, G. P., Ahmed, M. E., Raikwar, S. P., Thangavel, R., Khan, A. C., Zaheer, S. A., Iyer, S. S., Burton, C., James, D., et al. (2020) · The Neuroscientist · doi:10.1177/1073858420941476 · Cited by 302
Metadata
- Authors
- Sun, X., Wang, T., Cai, D., Hu, Z., Chen, J., Liao, H., Zhi, L., Wei, H., Zhang, Z., Qiu, Y., Wang, J., & Wang, A.
- Affiliations
- Chinese People's Liberation Army (CN)
- Nanjing University of Chinese Medicine (CN)
- Jiangsu Province Hospital (CN)
- Nanjing Drum Tower Hospital (CN)
- Corresponding author
- Wang, Jing
- Wang, Aiping
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 53
- Pages
- 38-42
- ISSN
- 1359-6101 (ISSN-L)
- PMC
- PMC7182527
- OpenAlex
- W3019663170
- Cited by
- 513
- References
- 36
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 32 · 2023: 77 · 2022: 110 · 2021: 160 · 2020: 102
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cytokine & Growth Factor Reviews (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Keywords
- cytokine storm, COVID-19 pandemic, SARS-CoV-2, COVID-19 pneumonia, cytokine monitoring, multiple organ failure, immune dysregulation, cytokine production, mortality, SARS, MERS, influenza, antiviral therapy
- MeSH terms
- Betacoronavirus, Continuous Renal Replacement Therapy, Cytokine Release Syndrome, COVID-19, SARS-CoV-2, Adrenal Cortex Hormones, Antibodies, Monoclonal, Female, Humans, Male, Multiple Organ Failure, Pneumonia, Viral, Polyethylene Glycols, Recombinant Proteins, Retrospective Studies, Cytokines, Interferon-alpha, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
